Literature DB >> 12866359

Neutral sphingomyelinase inhibitor C11AG prevents lipopolysaccharide-induced macrophage activation.

E Amtmann1, W Baader, M Zöller.   

Abstract

Stimulation of macrophages by lipopolysaccharide (LPS) leads to the synthesis of proinflammatory cytokines and nitric oxide (NO) and, as a consequence, to endotoxic shock. We provide evidence that LPS stimulates the activity of a membrane-associated neutral sphingomyelinase (nSMase) and that this activity is mandatory for the liberation of nuclear factor-kappa B (NF kappa B) and the induction of inducible NO-synthase (iNOS). With the aid of a newly developed, selective inhibitor of nSMase, C11AG, we could distinguish between nSMase-dependent and -independent LPS-induced signals. C11AG blocked LPS-stimulated sphingomyelin degradation and NF kappa B activation without interfering with p42 tyrosine phosphorylation. Concomitantly, the expression of iNOS was found to be reduced both in mononuclear cells and in murine endotoxemia. Therefore, specific inhibitors of nSMase may define a new class of antiinflammatory substances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866359

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  8 in total

1.  nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice.

Authors:  Tom Lallemand; Myriam Rouahi; Audrey Swiader; Marie-Hélène Grazide; Nancy Geoffre; Paul Alayrac; Emeline Recazens; Agnès Coste; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-24       Impact factor: 8.311

Review 2.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

3.  An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.

Authors:  Robert G Sitrin; Timothy M Sassanella; Howard R Petty
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-08       Impact factor: 6.914

Review 4.  Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.

Authors:  Mariana N Nikolova-Karakashian; Michael B Reid
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

Review 5.  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.

Authors:  Jan Skácel; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

6.  Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages.

Authors:  Samar M Hammad; Heather G Crellin; Bill X Wu; Jessica Melton; Viviana Anelli; Lina M Obeid
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-11-24       Impact factor: 3.072

Review 7.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013

8.  Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.

Authors:  Mariana Figuera-Losada; Marigo Stathis; Joelle M Dorskind; Ajit G Thomas; Veera Venkata Ratnam Bandaru; Seung-Wan Yoo; Nicholas J Westwood; Graeme W Rogers; Justin C McArthur; Norman J Haughey; Barbara S Slusher; Camilo Rojas
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.